These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 1280287

  • 1. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 2. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ, Ho KK, Lazarus L.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [Abstract] [Full Text] [Related]

  • 3. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 4. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 6. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF, Harman SM, Cho DE, Blackman MR.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [Abstract] [Full Text] [Related]

  • 7. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 8. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 9. Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women.
    Słowińska-Srzednicka J, Zgliczyński S, Chotkowska E, Srzednicki M, Stopińska-Głuszak U, Jeske W, Brzezińska A, Zgliczyński W, Sadowski Z.
    J Intern Med; 1993 Nov; 234(5):447-51. PubMed ID: 7693846
    [Abstract] [Full Text] [Related]

  • 10. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
    Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
    [Abstract] [Full Text] [Related]

  • 11. Oral 17beta-estradiol and sequential progesterone in menopause: effects on insulin-like growth factors and their binding proteins.
    Mozzanega B, Babbo GL, Salmaso L, De Toni R, Schiavo A, Mioni R, de Kreutzenberg SV.
    Gynecol Endocrinol; 2007 Jan; 23(1):50-7. PubMed ID: 17484513
    [Abstract] [Full Text] [Related]

  • 12. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 13. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Oct; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 14. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 15. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C, Colombo P, De Aloysio D, Gambacciani M, Grazioli I, Nappi C, Serra GB, Genazzani AR.
    Maturitas; 2002 Apr 25; 41(4):299-311. PubMed ID: 12034517
    [Abstract] [Full Text] [Related]

  • 16. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.
    Fertil Steril; 2003 Mar 25; 79(3):534-42. PubMed ID: 12620436
    [Abstract] [Full Text] [Related]

  • 17. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May 25; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 18. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 25; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 19. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC.
    Obstet Gynecol; 1997 Dec 25; 90(6):995-8. PubMed ID: 9397118
    [Abstract] [Full Text] [Related]

  • 20. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar 25; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.